ENSC
Price
$1.59
Change
+$0.02 (+1.27%)
Updated
Dec 3 closing price
Capitalization
5.78M
Intraday BUY SELL Signals
ITRM
Price
$0.42
Change
+$0.01 (+2.44%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
24.11M
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENSC vs ITRM

Header iconENSC vs ITRM Comparison
Open Charts ENSC vs ITRMBanner chart's image
Ensysce Biosciences
Price$1.59
Change+$0.02 (+1.27%)
Volume$49.03K
Capitalization5.78M
Iterum Therapeutics
Price$0.42
Change+$0.01 (+2.44%)
Volume$1.5K
Capitalization24.11M
ENSC vs ITRM Comparison Chart in %
ENSC
Daily Signal:
Gain/Loss:
ITRM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ENSC vs. ITRM commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Hold and ITRM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ENSC: $1.57 vs. ITRM: $0.42)
Brand notoriety: ENSC and ITRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 34% vs. ITRM: 36%
Market capitalization -- ENSC: $5.84M vs. ITRM: $24.11M
ENSC [@Biotechnology] is valued at $5.84M. ITRM’s [@Biotechnology] market capitalization is $24.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 0 FA rating(s) are green whileITRM’s FA Score has 1 green FA rating(s).

  • ENSC’s FA Score: 0 green, 5 red.
  • ITRM’s FA Score: 1 green, 4 red.
According to our system of comparison, ITRM is a better buy in the long-term than ENSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 4 TA indicator(s) are bullish while ITRM’s TA Score has 5 bullish TA indicator(s).

  • ENSC’s TA Score: 4 bullish, 3 bearish.
  • ITRM’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ITRM is a better buy in the short-term than ENSC.

Price Growth

ENSC (@Biotechnology) experienced а -7.94% price change this week, while ITRM (@Biotechnology) price change was -4.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

ITRM is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ITRM($24.1M) has a higher market cap than ENSC($5.78M). ITRM YTD gains are higher at: -76.328 vs. ENSC (-80.774). ENSC has higher annual earnings (EBITDA): -6.56M vs. ITRM (-20.51M). ITRM has more cash in the bank: 13M vs. ENSC (2.21M). ENSC has less debt than ITRM: ENSC (425K) vs ITRM (32.6M). ENSC (0) and ITRM (0) have equivalent revenues.
ENSCITRMENSC / ITRM
Capitalization5.78M24.1M24%
EBITDA-6.56M-20.51M32%
Gain YTD-80.774-76.328106%
P/E Ratio0.02N/A-
Revenue00-
Total Cash2.21M13M17%
Total Debt425K32.6M1%
FUNDAMENTALS RATINGS
ENSC vs ITRM: Fundamental Ratings
ENSC
ITRM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8794
P/E GROWTH RATING
1..100
672
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENSC's Valuation (36) in the null industry is in the same range as ITRM (62) in the Biotechnology industry. This means that ENSC’s stock grew similarly to ITRM’s over the last 12 months.

ENSC's Profit vs Risk Rating (100) in the null industry is in the same range as ITRM (100) in the Biotechnology industry. This means that ENSC’s stock grew similarly to ITRM’s over the last 12 months.

ENSC's SMR Rating (100) in the null industry is in the same range as ITRM (100) in the Biotechnology industry. This means that ENSC’s stock grew similarly to ITRM’s over the last 12 months.

ENSC's Price Growth Rating (87) in the null industry is in the same range as ITRM (94) in the Biotechnology industry. This means that ENSC’s stock grew similarly to ITRM’s over the last 12 months.

ITRM's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for ENSC (67) in the null industry. This means that ITRM’s stock grew somewhat faster than ENSC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENSCITRM
RSI
ODDS (%)
Bullish Trend 6 days ago
89%
Bullish Trend 6 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
84%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bullish Trend 6 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
78%
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ENSC
Daily Signal:
Gain/Loss:
ITRM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAA135.23-0.14
-0.11%
Mid-America Apartment Communities
DNA8.59-0.06
-0.69%
Ginkgo Bioworks Holdings
BAER1.65-0.03
-1.79%
Bridger Aerospace Group Holdings
ITGR69.95-1.80
-2.51%
Integer Holdings Corp
REVB0.92-0.04
-3.77%
Revelation Biosciences Inc

ENSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with MLLCF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then MLLCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
-4.57%
MLLCF - ENSC
37%
Loosely correlated
N/A
HNSBF - ENSC
33%
Loosely correlated
N/A
ATOS - ENSC
33%
Loosely correlated
-5.61%
ITRM - ENSC
32%
Poorly correlated
-7.10%
LCTX - ENSC
32%
Poorly correlated
-3.92%
More

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with SNTI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
-7.10%
SNTI - ITRM
35%
Loosely correlated
+4.37%
TARA - ITRM
35%
Loosely correlated
-7.79%
ENSC - ITRM
35%
Loosely correlated
-4.57%
RGNX - ITRM
34%
Loosely correlated
-3.10%
ORMP - ITRM
34%
Loosely correlated
+0.36%
More